FDA’s letter to medical device maker iRhythm is a warning for the industry

[cafead]

via Heart monitoring company iRhythm is in hot water with the Food and Drug Administration, which issued a stern warning letter to the device maker this week for marketing its product for “high risk” patients and changing its algorithm without seeking the FDA’s permission.

article source